Lenakast 25 mg Capsule
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Lenakast 25 mg Capsule is an anti-cancer medicine that belongs to a group of medicines affecting the function of the immune system, and contains lenalidomide. Its labelling describes it for the treatment of multiple myeloma and myelodysplastic syndrome, and also for lepra reaction. It is described as improving the immune system so it attacks cancer cells, helping the bone marrow produce healthier blood cells and more red blood cells (reducing the need for frequent blood transfusions), preventing the growth of new blood vessels in the tumour, and reducing cancer-cell growth by restricting the production of chemical messengers.
Product Information
The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of multiple myeloma
- Described for the treatment of myelodysplastic syndrome
- Described for the treatment of lepra reaction
- Described as improving red blood cell production and reducing the need for frequent blood transfusions
Described Dosage & Administration
- Taken only if prescribed by the doctor
- The dosage and duration advised by the doctor should be strictly followed
Described Side Effects
Described side effects include:
- Itching and rash
- Diarrhoea
- Low blood platelets and decreased white blood cell count
- Peripheral edema
- Cough, upper respiratory tract infection, and nasopharyngitis
- Back pain and joint pain
- Decreased appetite
- Headache and dizziness
- Nausea
- Breathlessness
- Fatigue
Some of these are described as persisting for a long time; a doctor should be consulted if symptoms last long.
Precautions
- Described as unsafe for pregnant women
- Described as safe for breastfeeding mothers only if prescribed by the doctor
- Described as unsafe to drive after use
- Used with caution in patients with kidney and liver-related issues
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains lenalidomide and is used for multiple myeloma, myelodysplastic syndrome, and lepra reaction. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as improving the immune system to attack cancer cells, supporting healthier blood cell production in the bone marrow, preventing tumour blood-vessel growth, and restricting chemical messengers that drive cancer-cell growth.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.